Quick Answer
Traws Pharma, Inc. reported Operating Income of -$142.37 million for fiscal year 2024.
Traws Pharma, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$142.37M | -601.4% |
| 2023 | -$20.30M | -3.4% |
| 2022 | -$19.63M | -19.0% |
| 2021 | -$16.50M | +34.0% |
| 2020 | -$24.99M | -15.2% |
| 2019 | -$21.70M | +6.8% |
| 2018 | -$23.28M | +9.5% |
| 2017 | -$25.74M | -8.6% |
| 2016 | -$23.70M | +1.1% |
| 2015 | -$23.97M | +62.4% |
| 2014 | -$63.74M | -2.4% |
| 2013 | -$62.22M | -179.3% |
| 2012 | -$22.28M | +19.2% |
| 2011 | -$27.57M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.05M | +52.5% | -224.7% |
| June 30, 2025 | -$1.25M | +99.0% | +76.0% |
| March 31, 2025 | -$5.20M | +0.2% | +39.0% |
| September 30, 2024 | -$8.54M | -67.7% | +93.1% |
| June 30, 2024 | -$123.35M | -2575.7% | -2266.6% |
| March 31, 2024 | -$5.21M | +15.1% | -2.4% |
| September 30, 2023 | -$5.09M | +9.8% | -10.4% |
| June 30, 2023 | -$4.61M | -11.9% | +24.9% |
- Traws Pharma, Inc. showed a decrease of -601.4% in Operating Income compared to the prior fiscal year.
- Over the 2011–2024 period, Traws Pharma, Inc.’s operating income has declined by 416.4% (from -$27.57 million to -$142.37 million).
- The most recent figure is from Traws Pharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: